| Page 18 | Kisaco Research
 

David Jorden

CEO
AURX

David Jorden

CEO
AURX

David Jorden

CEO
AURX
 

David Jordan

CEO
AURX

David Jordan

CEO
AURX

David Jordan

CEO
AURX
 
Join us at the 6th Connected Health & Fitness Summit (formerly known as Fitness & Active Brands) to find out how to future-proof your company, position yourself for growth, explore new business models and attract, engage and retain your customer base, throughout 2023 and beyond.
 

Nick Giannuzzi

Managing Partner & Co-Founder
Humble Growth

Nick Giannuzzi

Managing Partner & Co-Founder
Humble Growth

Nick Giannuzzi

Managing Partner & Co-Founder
Humble Growth
 

Jeff Echols

VP of Strategic Partners
Hammerspace

With a dynamic 20-year career in enterprise software, Jeff Echols has established himself as a leader in building differentiated solutions, strategic relationships, and driving joint partner success. He is currently the VP of Strategic Partners at Hammerspace, focusing on the company's AI Solutions and go-to-market strategy. His extensive experience spans enterprise and startup environments, including two IPOs and international assignments.

Jeff Echols

VP of Strategic Partners
Hammerspace

Jeff Echols

VP of Strategic Partners
Hammerspace

With a dynamic 20-year career in enterprise software, Jeff Echols has established himself as a leader in building differentiated solutions, strategic relationships, and driving joint partner success. He is currently the VP of Strategic Partners at Hammerspace, focusing on the company's AI Solutions and go-to-market strategy. His extensive experience spans enterprise and startup environments, including two IPOs and international assignments. Throughout his career at companies like WEKA, Nutanix, and CommVault, Jeff has led sales, product marketing, and corporate strategy teams, contributing to significant revenue growth and market differentiation.

 

Dr. Robert Huizinga

Interim Chief Executive Officer
Kane Biotech

Dr. Robert Huizinga

Interim Chief Executive Officer
Kane Biotech

Dr. Robert Huizinga

Interim Chief Executive Officer
Kane Biotech